Fenwick Represents DrChrono in $20 Million Growth Capital Round

Fenwick & West represented DrChrono Inc., a company developing a platform and services for modern medical practices to make care more informed, more interactive, and more personalized, in its $20 million growth capital round from ORIX Growth Capital.

DrChrono will use the funding to spur expansion and increase market share through further investing in the technology platform (EHR, medical billing and API) and expansion of engineering, sales, and support functions. More information about the financing can be obtained from DrChrono’s announcement.

The Fenwick transaction team was led by corporate partner Samuel Angus.